Kimberly Weaver, MD
Gastroenterology · Pittsburgh, PANPI 1790104925
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,820 of the $18,475 with a category attached, or 74.8%. 12 manufacturers reported payments, led by AbbVie at 34.3% of the total. Reporting peaked in 2022 at $7,551 and has fallen 91.6% since, to $632 in 2025.
Across 147 payments — averaging $125.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- E.r. Squibb & Sons, L.L.C.$6K
- Johnson & Johnson$5K
- Bristol Myers Squibb$812
- Takeda Pharmaceuticals U.S.A., Inc.$358
- Pfizer$187
- plus $235 from 6 others
What the payments were for
- Consulting fees$13,82075%
- Travel & lodging$1,7539%
- Food & beverage$2,75415%
- Education$1481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $6,344 |
| E.r. Squibb & Sons, L.L.C. | 8 | $5,584 |
| Johnson & Johnson | 43 | $4,955 |
| Bristol Myers Squibb | 11 | $812 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $358 |
| Pfizer | 5 | $187 |
| Phathom Pharmaceuticals, Inc. | 3 | $79 |
| Ipsen Biopharmaceuticals, Inc | 2 | $44 |
| Boehringer Ingelheim | 2 | $41 |
| Lilly USA, LLC | 2 | $39 |
| Sanofi | 1 | $16 |
| Celltrion USA Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,475 in reported general payments places this provider in the 85th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 61 | $24,096 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 44 | $2,834 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 15 | $2,361 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 79 | $1,503 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 31 | $528 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $323 |
| Omeprazole | 20 | $237 |
| Pantoprazole Sodium | 17 | $93 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Pittsburgh
- Miguel RegueiroPittsburgh$1.5M
- Sandra El-HachemPittsburgh$472K
- Elie AounPittsburgh$323K
- Gursimran KochharPittsburgh$217K
- Michael BabichPittsburgh$157K
- Heitham Abdul-BakiPittsburgh$92K
- Katie FarahPittsburgh$55K
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Harshit KharaDanville$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.